Search

Your search keyword '"Radford‐Smith, Graham L."' showing total 278 results

Search Constraints

Start Over You searched for: Author "Radford‐Smith, Graham L." Remove constraint Author: "Radford‐Smith, Graham L."
278 results on '"Radford‐Smith, Graham L."'

Search Results

1. Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility

3. Genome-wide association study of intraocular pressure uncovers new pathways to glaucoma

5. An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative Colitis

6. NLRP1 restricts butyrate producing commensals to exacerbate inflammatory bowel disease

10. 900 PREDICT UC: OPTIMISING INFLIXIMAB INDUCTION THERAPY FOR ACUTE SEVERE ULCERATIVE COLITIS - A RANDOMISED CONTROLLED TRIAL

11. Tu1891 THE REAL-WORLD USE OF FIVE-AMINOSALICYLATE (5ASA) TREATMENT FOR ULCERATIVE COLITIS IN AUSTRALIA AND NEW ZEALAND: CROHN'S COLITIS CURE (CCC) DATA INSIGHT'S PROGRAM

16. Su1760 CLINICAL AND ENDOSCOPIC REMISSION AT 3 MONTHS AFTER ACUTE SEVERE ULCERATIVE COLITIS IS PREDICTIVE OF MAINTENANCE THERAPY OUTCOMES AT 12 MONTHS - RESULTS FROM PREDICT UC

17. An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative Colitis.

18. Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma

19. Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian study

20. The Effect on Melanoma Risk of Genes Previously Associated With Telomere Length

22. An extremes of phenotype approach confirms significant genetic heterogeneity in patients with ulcerative colitis

24. Clinical pharmacology of AMG 181, a gut-specific human anti-α4β7 monoclonal antibody, for treating inflammatory bowel diseases

28. Tu1749 POST-USTEKINUMAB INDUCTION IL-12, IL-23, AND USTEKINUMAB LEVELS ARE ASSOCIATED WITH CLINICAL RESPONSE IN A MULTICENTRE PROSPECTIVE COHORT STUDY OF CROHN'S DISEASE PATIENTS: RESULTS FROM THE AURORA STUDY

29. Su1733 BASELINE CYTOKINE LEVELS AND MICROBIOME SIGNATURES ARE ASSOCITED WITH CLINICAL RESPONSE FOLLOWING USTEKINUMAB INDUCTION IN A MULTI-CENTRE PROSPECTIVE COHORT STUDY OF CROHN'S DISEASE PATIENTS: RESULTS FROM THE AURORA STUDY

30. 962 EARLY LIFE EXPOSURE TO PARENTAL CROHN'S DISEASE IS ASSOCIATED WITH ALTERED GUT MICROBIOME COMPOSITION, IMPAIRED GUT PERMEABILITY, AND INCREASED RISK OF INCIDENT CROHN'S DISEASE

35. Publisher Correction: Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways

36. Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways (vol 9, 4774, 2018)

39. Level of UV Exposure, Skin Type, and Age Are More Important than Thiopurine Use for Keratinocyte Carcinoma Development in IBD Patients

40. Thiopurine Therapy in Inflammatory Bowel Diseases: Making New Friends Should Not Mean Losing Old Ones

43. NLRP1 restricts butyrate producing commensals to exacerbate inflammatory bowel disease

44. Dietary patterns and the development of Crohn’s disease (CD)

46. Su1909 - Crohn's Disease Patients with at Least 1 Nod2 Mutations and Who Smoke Regularly are Four Times as Likely to Need two or more Resections

47. Tu1807 - Genetically Distinct Signatures of Mild and Severe Ulcerative Colitis

48. Tu1020 - Crohn's Colitis Care (CCcare) - Development and Testing of a Bespoke Cloud-Based Clinical Management System for Inflammatory Bowel Disease (IBD)

50. Mo1888 - Infliximab Salvage Therapy in Acute Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis

Catalog

Books, media, physical & digital resources